12 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... drugs. ... #pharmacology #dm2 ... #overview #management ... #comparison
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Comparison #Table ... #HalfLife #Dosing ... Loop #Thiazide #CHF ... #Cardiology #Management
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
suspension DOSING ... drugs by at least ... patients with CKD, HF ... , or diabetes. ... #Pharmacology
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Arrhythmias / CHB ... pharmacology ... #pharmacology # ... inopressors #diagnosis #management ... #comparison #table
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors - Normal ... and Renal Dosing ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... #medications #table ... hematology #warfarin #dosing
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
strongly consider using ... decompensated CHF ... #Medications #management ... #treatment #comparison ... #table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... order for the drug ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology #
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
sx overlap with normal ... May have typical HF ... Management during ... Management during ... Management during
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
neuroexam - Oral ... disease b) CHF ... Insulin dependent DM ... Diabetes regimen ... medical and surgical management